VUMERITY for the Treatment of Multiple Sclerosis, USA
Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action - The Lancet Neurology
COPAXONE® Glatiramer acetate - ppt download
IJMS | Free Full-Text | Glatiramer Acetate in Treatment of Multiple Sclerosis: A Toolbox of Random Co-Polymers for Targeting Inflammatory Mechanisms of both the Innate and Adaptive Immune System? | HTML
IJMS | Free Full-Text | New Insights into Multiple Sclerosis Mechanisms: Lipids on the Track to Control Inflammation and Neurodegeneration | HTML
Multiple Sclerosis | NEJM
Mechanisms of Action of Glatiramer Acetate in the Treatment of Multiple Sclerosis - ScienceDirect
The heritage of glatiramer acetate and its use in multiple sclerosis | Multiple Sclerosis and Demyelinating Disorders | Full Text
Frontiers | The Role of B Cells in Primary Progressive Multiple Sclerosis | Neurology
Glatiramer acetate attenuates the activation of CD4+ T cells by modulating STAT1 and −3 signaling in glia | Scientific Reports
Glatiramer Acetate modulates ion channels expression and calcium homeostasis in B cell of patients with relapsing-remitting multiple sclerosis | Scientific Reports
Teriflunomide in multiple sclerosis: an update | Neurodegenerative Disease Management
Acting centrally or peripherally: A renewed interest in the central nervous system penetration of disease-modifying drugs in multiple sclerosis - Multiple Sclerosis and Related Disorders
The mechanism of action of glatiramer acetate treatment in multiple sclerosis | Neurology
Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis | SpringerLink
Glatiramer acetate for treatment of MS: Regulatory B cells join the cast of players | Semantic Scholar
Glatiramer acetate http://db.doyma.es/cgi-bin/wdbcgi.exe/doyma/mrevista.pubmed_full?rev=19&vol=17&num=5&pag=244 Neurologia 2002 May;17(5):244-58 Comi G, Moiola L. Head of the Departments of Neurology and Neurophysiology. University Vita ...
Overview of glatiramer acetate mechanism of action. Abbreviations: APC,... | Download Scientific Diagram
Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines | PNAS
Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis | Neurology
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
Exome sequencing in multiple sclerosis families identifies 12 candidate genes and nominates biological pathways for the genesis of disease
Glatiramer Acetate Treatment of Multiple Sclerosis: An Immunological Perspective | The Journal of Immunology
